Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer

Gene Therapy

Volumn 4, Issue 5, 1997, Pages 465-472

  Larochelle, N ^a   Lochmuller H ^a,d   Zhao, J ^a   Jani, A ^a   Hallauer, P ^a   Hastings, K E M ^a   Massie, B ^b   Prescott, S ^a   Petrof, B J ^c   Karpati, G ^a   Nalbantoglu, J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenovirus; Gene therapy; Muscle creatine kinase; Muscle specific expression; Promoter

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; CREATINE KINASE; DYSTROPHIN; LUCIFERASE; MUSCLE ENZYME; TROPONIN I; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENHANCER REGION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; IMMUNE DEFICIENCY; KIDNEY CELL; LIVER CELL; LUNG ALVEOLUS CELL; MOUSE; MUSCLE CELL; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SKELETAL MUSCLE; TISSUE SPECIFICITY; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS;

EID: 8244264752     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300414     Document Type: Article

References (49)

1. Karpati G, Acsadi G. The principles of gene therapy in Duchenne muscular dystrophy. Clin Invest Med 1994; 17: 499-509.
2. Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors, Curr Opin Gene Dev 1993; 3: 499-503.
3. Bergsma DJ, Grichnik JM, Gossett LMA, Schwartz RJ. Delimitation and characterization of cis-acting DNA sequences required for the regulated expression and transcriptional control of the chicken skeletal α-actin gene. Mol Cell Biol 1986; 6: 2462-2475.
4. Muscat GEO, Kedes L. Multiple 5′-flankmg regions of the human ′-skeletal actin gene synergistically modulate muscle specific expression. Mol Cell Biol 1987; 7: 4089-4099.
5. Walsh K, Schimmel P. DNA-binding site for two skeletal actin promoter factors is important for expression in muscle cells. Mol Cell Biol 1988; 8: 1800-1802.
6. Minty A, Kedes L. Upstream regions of the human cardiac actin gene that modulate its transcription in muscle cells: presence of an evolutionarily conserved repeated motif. Mol Cell Biol 1986; 6: 2125-2136.
7. Miwa T, Kedes L. Duplicated CArG box domains have positive and mutually dependent regulatory roles in expression of the human α-cardiac actin gene Mol Cell Biol 1987; 7: 2803-2813.
8. Mohun TJ, Garrett N, Gurdon JB. Upstream sequences required for tissue-specific activation of the cardiac actin gene in Xenopus laevis embryos. EMBO J 1986; 5: 3185-3193.
9. Konieczny SF, Emerson CP. Complex regulation of the muscle-specific contractile protein (troponin I) gene. Mol Cell Biol 1987; 7: 3065-3075.
10. Arnold HH, Tannich E, Paterson BM. The promoter of the chicken cardiac myosin light chain 2 gene shows cell-specific expression in transfected primary cultures of chicken muscles. Nucleic Acid Res 1988; 16: 2411-2429.
11. Bouvaget PF et al. Multiple positive and negative 5′ regulatory elements control the cell-type-specific expression of the embryonic skeletal myosin heavy-chain gene. Mol Cell Biol 1987; 7: 4377-089.
12. Urdal P, Urdal K, Stromme JH. Cytoplasmic creatine kinase isoenzymes quantitated in tissue specimens obtained at surgery. Clin Chem 1983; 29: 310-313.
13. Kwiatkowski RV, Ehrismann R, Schweinfest CW, Dottin RP. Accumulation of creatine kinase mRNA during myogenesis: molecular cloning of a β-creatine kinase cDNA. Dev Biol 1985; 112: 84-88.
14. Ritchie ME, Trask RV, Fontanet HL, Billadello JJ. Multiple positive and negative elements regulate human brain creatine kinase gene expression. Nucleic Acids Res 1991; 19: 6231-6240.
15. Johnson JE, Wold BJ, Hauschka SD. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol Cell Biol 1989; 9: 3393-3399.
16. Jaynes J et al Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts. Mol Cell Biol 1986; 6: 2855-2864.
17. Jaynes JD et al. The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol Cell Biol 1988; 8: 62-70.
18. Sternberg EA et al. Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene. Mol Cell Biol 1988; 8: 2896-2909.
19. Amacher SL, Buskin JN, Hauschka SD. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol Cell Biol 1993; 13: 2753-2764.
20. Buskin JN, Hauschka SD. Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol Cell Biol 1989; 9: 2627-2640.
21. Wilkinson JM, Grand RJA. Comparison of amino acid sequence of troponin I from different striated muscles. Nature 1978; 271: 31-35.
22. Koppe RI, Hallauer PL, Karpati G, Hastings K. cDNA clone and expression analysis of rodent fast and slow skeletal muscle troponin I mRNAs. J Biol Chem 1989; 264: 14327-14333.
23. Hastings K et al. Structure and developmental regulation of troponin I isoforms: cDNA clone analysis of avian cardiac troponin I mRNA. J Biol Chem 1991; 266: 19659-19665.
24. Guenet J-I et al. Cardiac and skeletal troponin I isoforms are encoded by a dispersed gene family on mouse chromosomes 1 and 7. Genome 1996; 7: 13-15.
25. Pette D, Staron RS. Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol 1990; 116: 1-76.
26. Bandman E. Contractile protein isoforms in muscle development. Dev Biol 1992; 154: 273-283.
27. Yutzey KE, Kline RL, Konieczny SF. An internal regulatory element controls troponin I gene expression. Mol Cell Biol 1989; 9: 1397-1405.
28. Lin H, Yutzey KE, Komeczny SF. Muscle-specific expression of the troponin I gene requires interactions between helix-loophelix muscle regulatory factors and ubiquitous transcription factors. Mol Cell Biol 1991; 11: 267-280.
29. Acsadi G et al A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet 1994; 3: 579-584.
30. Acsadi G et al. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther 1996; 7: 129-140.
31. Kochanek S et al. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc Nat! Acad Sci USA 1996; 93: 5731-5736.
32. Friedman JM, Babiss LE, Clayton DF, Darnell JE. Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression. Mol Cell Biol 1986; 6: 3791-3797.
33. Quantin B, Perricaudet L, Tajbakhsh S, Mandel L. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 1992; 89: 2581-2584.
34. Hashimoto M et al. A neural cell-type-specific expression system using recombinant adenovirus vectors. Hum Gene Ther 1996; 7: 149-158.
35. Imler J-L et al. Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter. Gene Therapy 1996; 3: 49-58.
36. Connelly S, Gardner JM, McClelland A, Kaleko, M. High level tissue-specific expression of functional human factor VIII in mice. Hum Gene Ther 1996; 7: 183-195.
37. Babiss LE, Friedman JM, Darnell JE. Cellular promoters incorporated into the adenovirus genome: effects of viral regulatory elements on transcription rates and cell specificity of albumin and B-globin promoters. Mol Cell Biol 1986; 6: 3798-3806.
38. Jones WK, Sanchez A, Robbins J. Murine pulmonary myocardium: developmental analysis of cardiac gene expression. Dev Dynamics 1994; 200: 117-128.
39. Hallauer PL, Bradshaw HL, Hastings KE. Complex fiber-type-specific expression of fast skeletal muscle troponin I gene constructs in transgenic mice. Development 1993; 119: 691-701.
40. Dai Y, Roman M, Naviaux RK, Verma IM. Gene therapy via primary myoblasts. long term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 1992; 89: 10892-10895.
41. Ferrari G et al. A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers. Hum Gene Ther 1995; 6: 733-742.
42. Donoviel DB et al. Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice. Mol Cell Biol 1996; 16: 1649-1658.
43. Acsadi G, Massie B, Jani A. Adenovirus-mediated gene transfer into striated muscles. J Mol Med 1995; 73: 165-180.
44. Wang Q, Jia X-C, Finer MH. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Gene Therapy 1995; 2: 775-783.
45. Cox GA et al. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 1993; 364: 725-729.
46. Huard J et al. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Therapy 1995; 2: 107-115.
47. Higuchi I et al. Detection of HTLV-1 provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis. Muscle Nerve 1995; 18: 854-858.
48. Gressens P, Martin JR. HSV-2 DNA persistence in astrocytes of the trigeminal root entry zone: double labeling by in situ PCR and immunohistochemistry. J Neuropath Exp Neural 1994; 53: 127-135.
49. Chroboczek J, Bieber F, Jacrot B. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 1992; 186: 280-285.